Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes.

Abstract excerpt

The past 3 decades have been characterized by an exponential growth in knowledge and advances in the clinical treatment of atrial fibrillation (AF). It is now known that AF genesis requires a vulnerable atrial substrate and that the formation and composition of this substrate may vary depending on comorbid conditions, genetics, sex, and other factors. Population-based studies have identified numerous factors that...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Comorbidity
• Share to Action Potentials
• Share to Atrial Fibrillation